World's Best Scientists 2026 revealed!
Antoine Magnan

Antoine Magnan

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Microbiology 63 2766 2534 166 157 303 12855

Antoine Magnan publications per year

The chart shows the history of publications by Antoine Magnan between 1988 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Antoine Magnan published across 38 years, from 1988 to 2025, averaging 10.6 papers a year. Output peaked at 33 publications in 2017. 23 of the 404 publications appeared in the last two years.

No. of publications
10 20 30
Bar chart. Horizontal axis: year, 1988 to 2025. Vertical axis: number of publications, 0 to 33. Peak 33 publications in 2017. 1988: 2 publications 1989: 0 publications 1990: 2 publications 1991: 0 publications 1992: 0 publications 1993: 2 publications 1994: 6 publications 1995: 3 publications 1996: 2 publications 1997: 2 publications 1998: 6 publications 1999: 6 publications 2000: 9 publications 2001: 8 publications 2002: 3 publications 2003: 7 publications 2004: 12 publications 2005: 12 publications 2006: 13 publications 2007: 10 publications 2008: 15 publications 2009: 9 publications 2010: 6 publications 2011: 14 publications 2012: 15 publications 2013: 17 publications 2014: 22 publications 2015: 25 publications 2016: 23 publications 2017: 33 publications 2018: 26 publications 2019: 15 publications 2020: 19 publications 2021: 14 publications 2022: 13 publications 2023: 10 publications 2024: 15 publications 2025: 8 publications
1988 2025

404 publications in total across all disciplines

View publications per year as a table
Antoine Magnan: publications per year, 1988 to 2025
Year Publications
1988 2
1989 0
1990 2
1991 0
1992 0
1993 2
1994 6
1995 3
1996 2
1997 2
1998 6
1999 6
2000 9
2001 8
2002 3
2003 7
2004 12
2005 12
2006 13
2007 10
2008 15
2009 9
2010 6
2011 14
2012 15
2013 17
2014 22
2015 25
2016 23
2017 33
2018 26
2019 15
2020 19
2021 14
2022 13
2023 10
2024 15
2025 8
Total 404
Download as CSV

Antoine Magnan publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Antoine Magnan sits on this spectrum.

No. of scientists
50 100 150 200 250
Bar chart with 64 bars. Horizontal axis: publications, 55–64 to 679+. Vertical axis: number of scientists, 0 to 288. Most scientists, 288, have 135–144 publications. The last bar groups every scientist with 679 publications or more. The highlighted bar, 295–304 publications, is where this scientist sits. 55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 265 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 234 scientists 205–214 publications: 208 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55–64 publications 679+

This scientist: 303 publications — 78th percentile

78% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

View publications distribution as a table
Number of Microbiology scientists by publication count, Research.com 2026 ranking edition. Based on 5,513 ranked scientists.
Publications Scientists This scientist
55–64 8
65–74 29
75–84 55
85–94 112
95–104 137
105–114 190
115–124 235
125–134 234
135–144 288
145–154 265
155–164 264
165–174 253
175–184 276
185–194 190
195–204 234
205–214 208
215–224 198
225–234 155
235–244 161
245–254 160
255–264 146
265–274 139
275–284 148
285–294 115
295–304 96 303
305–314 88
315–324 106
325–334 65
335–344 76
345–354 64
355–364 62
365–374 65
375–384 61
385–394 34
395–404 44
405–414 36
415–424 35
425–434 29
435–444 33
445–454 34
455–464 25
465–474 26
475–484 20
485–494 19
495–504 16
505–514 17
515–524 23
525–534 14
535–544 14
545–554 18
555–564 12
565–574 7
575–584 9
585–594 9
595–604 9
605–614 7
615–624 9
625–634 7
635–644 4
645–654 5
655–664 6
665–674 7
675–678 3
679+ 99
Download as CSV

Antoine Magnan D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Antoine Magnan sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 88 bars. Horizontal axis: D-Index, 40 to 127+. Vertical axis: number of scientists, 0 to 162. Most scientists, 162, have 58 D-Index. The last bar groups every scientist with 127 D-Index or more. The highlighted bar, 63 D-Index, is where this scientist sits. 40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 112 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 123 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 94 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 63 D-Index — 52nd percentile

52% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

View D-Index distribution as a table
Number of Microbiology scientists by D-index, Research.com 2026 ranking edition. Based on 5,513 ranked scientists.
D-Index Scientists This scientist
40 30
41 86
42 90
43 117
44 122
45 123
46 108
47 110
48 106
49 109
50 129
51 111
52 116
53 127
54 134
55 134
56 112
57 136
58 162
59 151
60 139
61 123
62 126
63 144 63
64 109
65 103
66 124
67 112
68 103
69 131
70 94
71 93
72 96
73 92
74 80
75 66
76 87
77 60
78 73
79 59
80 57
81 55
82 47
83 77
84 50
85 45
86 42
87 41
88 32
89 38
90 35
91 34
92 27
93 26
94 33
95 22
96 37
97 22
98 21
99 22
100 30
101 16
102 20
103 17
104 19
105 16
106 19
107 18
108 14
109 10
110 9
111 7
112 11
113 6
114 15
115 10
116 12
117 7
118 10
119 10
120 11
121 2
122 7
123 12
124 5
125 9
126 6
127+ 95
Download as CSV

Overview

Antoine Magnan is affiliated with the University of Nantes in France and has a substantial publication record predominantly in the field of Medicine, with a focus on Pulmonary and Respiratory Medicine, Physiology, Surgery, Immunology, and Immunology and Allergy.

The primary research topics covered by Magnan include:

  • Asthma and respiratory diseases
  • Transplantation: Methods and Outcomes
  • Allergic Rhinitis and Sensitization
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Respiratory and Cough-Related Research
  • Eosinophilic Disorders and Syndromes
  • Dermatology and Skin Diseases

Magnan has contributed extensively to several prominent publication venues, including:

  • Revue des Maladies Respiratoires
  • Revue des Maladies Respiratoires Actualités
  • Revue française d'allergologie
  • Frontiers in Immunology
  • Allergy

Notable recent papers authored or co-authored by Magnan encompass:

  • "Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial," 2020, The Lancet Respiratory Medicine
  • "Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study," 2023, The Lancet Respiratory Medicine
  • "Frequent Homozygous Deletions of Type I Interferon Genes in Pleural Mesothelioma Confer Sensitivity to Oncolytic Measles Virus," 2020, Journal of Thoracic Oncology
  • "Immunoglobulin E response in health and disease beyond allergic disorders," 2022, Allergy
  • "How can we minimise the use of regular oral corticosteroids in asthma?," 2020, European Respiratory Review

The scientist's frequent co-authors include:

  • Antoine Roux
  • Dorian Hassoun
  • Jérôme Le Pavec
  • Matthieu Glorion
  • Adrien Tissot

Best Publications

  • Effect of incorrect use of dry powder inhalers on management of patients with asthma and COPD

    Federico Lavorini;Antoine Magnan;Antoine Magnan;Jean Christophe Dubus;Thomas Voshaar

  • Efficacy of mepolizumab add-on therapy on health-related quality of life and markers of asthma control in severe eosinophilic asthma (MUSCA): a randomised, double-blind, placebo-controlled, parallel-group, multicentre, phase 3b trial.

    Geoffrey L Chupp;Eric S Bradford;Frank C Albers;Daniel J Bratton

  • IL-17 in severe asthma. Where do we stand?

    Julie Chesné;Faouzi Braza;Guillaume Mahay;Sophie Brouard

  • The need to improve inhalation technique in Europe: A report from the Aerosol Drug Management Improvement Team

    G.K. Crompton;P.J. Barnes;M. Broeders;C. Corrigan

  • Importance of inhaler devices in the management of airway disease

    J.C. Virchow;G.K. Crompton;R. Dal Negro;S. Pedersen

  • Platelet-derived growth factor expression in primary pulmonary hypertension: comparison of HIV seropositive and HIV seronegative patients.

    M Humbert;G Monti;M Fartoukh;A Magnan

  • Allergic vs nonallergic asthma: what makes the difference?

    Stéphanie Romanet-Manent;D Charpin;A Magnan;A Lanteaume

  • Assessment of the Th1/Th2 paradigm in whole blood in atopy and asthma. Increased IFN-gamma-producing CD8(+) T cells in asthma.

    Antoine O. Magnan;Laurent G. Mély;Christophe A. Camilla;Monique M. Badier

  • MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation

    J. Bousquet;H. J. Schunemann;J. Fonseca;B. Samolinski

  • Research needs in allergy: an EAACI position paper, in collaboration with EFA

    Nikolaos G Papadopoulos;Ioana Agache;Sevim Bavbek;Beatrice M Bilo

  • MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis

    Jean Bousquet;Holger J. Schünemann;Peter W. Hellings;Sylvie Arnavielhe

  • ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle

    J Bousquet;P W Hellings;I Agache;A Bedbrook

  • Tissue remodelling in chronic bronchial diseases: from the epithelial to mesenchymal phenotype

    Mallory Pain;Olga Bermudez;Olga Bermudez;Philippe Lacoste;Philippe Lacoste;Pierre-Joseph Royer;Pierre-Joseph Royer

  • A Proof-of-Concept, Randomized, Controlled Trial of Omalizumab in Patients With Severe, Difficult-to-Control, Nonatopic Asthma

    Gilles Garcia;Gilles Garcia;Antoine Magnan;Antoine Magnan;Raphaël Chiron;Cécile Contin-Bordes;Cécile Contin-Bordes

  • Masitinib, a c-kit/PDGF receptor tyrosine kinase inhibitor, improves disease control in severe corticosteroid-dependent asthmatics.

    M. Humbert;F. De Blay;G. Garcia;A. Prud’homme

  • Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology

    Jean Bousquet;Jean Bousquet;Peter W. Hellings;Ioana Agache;Flore Amat

  • Mesenchymal Stem Cells Induce Suppressive Macrophages Through Phagocytosis in a Mouse Model of Asthma.

    Faouzi Braza;Faouzi Braza;Stéphanie Dirou;Virginie Forest;Virginie Forest;Vincent Sauzeau;Vincent Sauzeau

  • EAACI position statement on asthma exacerbations and severe asthma

    A. Čustović;S.L. Johnston;I.D. Pavord;M. Gaga

  • Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial

    Tim W Harrison;Pascal Chanez;Francesco Menzella;Giorgio Walter Canonica

  • Allergen-specific immunotherapy in allergic rhinitis and asthma. Mechanisms and proof of efficacy.

    Anaïs Pipet;Anaïs Pipet;Karine Botturi;Karine Botturi;Domitille Pinot;Daniel Vervloet

  • Frequency and impact of allergic rhinitis in asthma patients in everyday general medical practice: a French observational cross-sectional study.

    A. Magnan;J. P. Meunier;C. Saugnac;J. Gasteau

  • Is diet partly responsible for differences in COVID-19 death rates between and within countries?

    Jean Bousquet;Josep M Anto;Guido Iaccarino;Wienczyslawa Czarlewski

  • CX3CR1 is required for airway inflammation by promoting T helper cell survival and maintenance in inflamed lung

    Cyrille Mionnet;Vanessa Buatois;Vanessa Buatois;Akira Kanda;Akira Kanda;Akira Kanda;Valerie Milcent;Valerie Milcent

  • A proof-of-concept randomized-controlled trial of omalizumab in patients with severe difficult to control nonatopic asthma

    Gilles Garcia;Antoine Magnan;Raphaël Chiron;Pierre-Olivier Girodet

Frequent Co-Authors

Sophie Brouard
Sophie Brouard University of Nantes
Marc Humbert
Marc Humbert University of Paris-Saclay
Daniel Vervloet
Daniel Vervloet Grenoble Alpes University
Pascal Demoly
Pascal Demoly University of Montpellier
Jean Bousquet
Jean Bousquet University of Montpellier
Inger Kull
Inger Kull Karolinska Institute
Adnan Custovic
Adnan Custovic Imperial College London
Piotr Kuna
Piotr Kuna Medical University of Lodz
Renaud Louis
Renaud Louis University of Liège

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in microbiology but seeking alternative or complementary career paths, exploring related online degrees can open diverse opportunities. For individuals facing unique challenges, such as those wondering what is the best degree for a convicted felon, certain online programs in health sciences and allied fields offer accessible routes to professional growth.

One promising area is healthcare, where specialized roles like a functional medicine nurse practitioner combine clinical expertise with holistic care principles. This pathway requires targeted education and certification, often available through flexible online programs tailored to working professionals.

Additionally, certifications such as the CPC certification provide a gateway to careers in medical coding and billing. These roles are critical in healthcare administration, supporting accurate documentation and reimbursement processes.

For those drawn to the administrative side of health services, programs focused on health information management offer viable career options. Understanding the health information management salary and career paths can help students evaluate the benefits of pursuing this degree, which emphasizes data management, compliance, and technology in healthcare settings.

Best Scientists Citing Antoine Magnan

Trending Scientists

Recently Published Articles